• Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor investor investor

€0.0

round
investor

€0.0

round
*

€650k

Seed
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR201920202021
Revenues000000000000
% growth-(95 %)-
EBITDA000000000000
Profit000000000000
EV000000000000
EV / revenue00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x
R&D budget000000000000

Source: Company filings or news article

Notes (0)
More about Seekyo Therapeutics
Made with AI
Edit

Seekyo Therapeutics is a biotechnology company focused on developing next-generation cancer treatments. The company specializes in Tumor Micro Environment (TME) Targeting Smart Chemotherapy, which aims to selectively target tumors while sparing healthy tissues. This approach is designed to reduce adverse effects and improve the quality of life for patients. Seekyo's technological platform offers bespoke optimization of both marketed and in-development drugs, making it a valuable partner for big pharma, biotech companies, and academic institutions. The company operates in the oncology market, primarily targeting solid tumors such as lung, breast, and pancreatic cancers. Seekyo's business model involves collaborating with partners to develop vectors for delivering original payloads and optimizing existing treatments. Revenue is generated through partnerships, research collaborations, and licensing agreements.

Keywords: biotechnology, cancer treatment, smart chemotherapy, tumor targeting, solid tumors, drug optimization, oncology, biotech partnerships, TME targeting, innovative therapy.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo